Tigecycline pharmacokinetic/pharmacodynamic update
Open Access
- 1 September 2008
- journal article
- review article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 62 (Supplement) , i11-i16
Abstract
This brief review summarizes recently published data on the pharmacokinetics and pharmacodynamics of tigecycline in man. Significant pharmacokinetic data are now available from the studies of infected patients, as is information on tissue distribution. Importantly, drug exposure–response relationships have been established for complicated skin and skin structure infections and intra-abdominal infection. These studies highlight the difficulties of undertaking pharmacodynamic studies in humans where account must be taken of both mixed pathogen infections and the potential impact of surgery. These data help to define the clinical role for tigecycline.Keywords
This publication has 7 references indexed in Scilit:
- Population Pharmacokinetics of Tigecycline in Patients with Complicated Intra-Abdominal or Skin and Skin Structure InfectionsAntimicrobial Agents and Chemotherapy, 2006
- Serum, tissue and body fluid concentrations of tigecycline after a single 100 mg doseJournal of Antimicrobial Chemotherapy, 2006
- Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclinesJournal of Antimicrobial Chemotherapy, 2006
- Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of TigecyclineJournal of Chemotherapy, 2005
- TigecyclineJournal of Antimicrobial Chemotherapy, 2005
- Penetration, efflux and intracellular activity of tigecycline in human polymorphonuclear neutrophils (PMNs)Journal of Antimicrobial Chemotherapy, 2005
- Pharmacokinetic/pharmacodynamic profile for tigecycline—a new glycylcycline antimicrobial agentDiagnostic Microbiology and Infectious Disease, 2005